Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.4) was added to the study history, replacing the previous v3.5.3 tag. This reflects an administrative update to the record history.
    Difference
    0.1%
    Check dated 2026-05-16T09:58:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov record history interface.
    Difference
    0.1%
    Check dated 2026-04-25T06:03:18.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history page.
    Difference
    0.1%
    Check dated 2026-04-18T03:50:21.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page history now includes a new revision labeled v3.5.0 and removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-20T04:55:31.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the record history and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:28:25.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added and the previous revision v3.4.1 was removed in the page history. This is a metadata update to the history log and does not affect study data or page functionality.
    Difference
    0.1%
    Check dated 2026-02-12T03:56:49.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.